نتائج البحث - "Muscarinic Antagonists"

المصدر: Lehmann, S, Ringbæk, T, Løkke, A, Grote, L, Hedner, J & Lindberg, E 2019, ' A randomized trial to determine the impact of indacaterol/glycopyrronium on nighttime oxygenation and symptoms in patients with moderate-to-severe COPD : the DuoSleep study ', International Journal of Chronic Obstructive Pulmonary Disease, vol. 14, pp. 199-210 . https://doi.org/10.2147/COPD.S184127Test
Lehmann, S, Ringbaek, T, Lokke, A, Grote, L, Hedner, J & Lindberg, E 2019, ' A randomized trial to determine the impact of indacaterol/glycopyrronium on nighttime oxygenation and symptoms in patients with moderate-to-severe COPD : the DuoSleep study ', International Journal of Chronic Obstructive Pulmonary Disease, vol. 14, pp. 199-210 . https://doi.org/10.2147/COPD.S184127Test
The International Journal of Chronic Obstructive Pulmonary Disease
International Journal of Chronic Obstructive Pulmonary Disease

مصطلحات موضوعية: Male, Time Factors, bronchodilator, Respiratory Medicine and Allergy, Health Status, Vital Capacity, Quinolones, THERAPY, Severity of Illness Index, DESATURATION, Pulmonary Disease, Chronic Obstructive, DOUBLE-BLIND, 0302 clinical medicine, Oxygen/blood, Bronchodilator Agents/administration & dosage, Forced Expiratory Volume, Surveys and Questionnaires, 030212 general & internal medicine, Lung, Original Research, Lungmedicin och allergi, Sleep disorder, COPD, Cross-Over Studies, integumentary system, Indans/administration & dosage, Norway, General Medicine, Middle Aged, Pulmonary Disease, Chronic Obstructive/blood, Bronchodilator Agents, Drug Combinations, Treatment Outcome, Anesthesia, Quinolones/administration & dosage, Indans, Female, medicine.symptom, Somnolence, medicine.drug, Adrenergic beta-2 Receptor Agonists/administration & dosage, Adult, Muscarinic Antagonists, International Journal of Chronic Obstructive Pulmonary Disease, Placebo, OBSTRUCTIVE PULMONARY-DISEASE, SALMETEROL-FLUTICASONE, 03 medical and health sciences, FEV1/FVC ratio, Double-Blind Method, GLYCOPYRRONIUM, medicine, Humans, sleep, Adrenergic beta-2 Receptor Agonists, Asthma, Aged, Lung/drug effects, hypoxia, business.industry, Muscarinic Antagonists/administration & dosage, lung function, STANDARDIZATION, biochemical phenomena, metabolism, and nutrition, medicine.disease, Glycopyrrolate, Crossover study, Oxygen, quality of life, 030228 respiratory system, Glycopyrrolate/administration & dosage, Quality of Life, Indacaterol, business, Sleep, Biomarkers, Biomarkers/blood

وصف الملف: application/pdf; text/html

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c48d2846d648e8f2dd6491368b8f863Test
https://curis.ku.dk/ws/files/235001089/copd_184127_a_randomized_trial_to_determine_the_impact_of_indacaterol_gl_010819.pdfTest

7

Navafenterol (AZD8871) in patients with COPD: a randomized, double-blind, phase I study evaluating safety and pharmacodynamics of single doses of this novel, inhaled, long-acting, dual-pharmacology bronchodilator

المؤلفون: Ulrika Wählby-Hamrén, Cristina Villarroel, Victor Balaguer, Alejhandra Lei, Beatriz Seoane, Dave Singh, Ajay Aggarwal, Eulalia Jimenez, Carol Astbury, Ioannis Psallidas

المصدر: Respiratory Research
Respiratory Research, Vol 21, Iss S1, Pp 1-11 (2020)

مصطلحات موضوعية: 0301 basic medicine, Male, Vital Capacity, Pulmonary Disease, Chronic Obstructive, 0302 clinical medicine, Bronchodilator, Forced Expiratory Volume, Lung, COPD, Cross-Over Studies, MABA, Middle Aged, Bronchodilator Agents, Treatment Outcome, Tolerability, England, Anesthesia, Quinolines, Female, Safety, medicine.drug, medicine.drug_class, Bronchoconstriction, Muscarinic Antagonists, Placebo, 03 medical and health sciences, Double-Blind Method, Dual-pharmacology muscarinic receptor antagonist β2-adrenoceptor agonist, Administration, Inhalation, medicine, Humans, Pharmacokinetics, Adverse effect, Adrenergic beta-2 Receptor Agonists, Aged, lcsh:RC705-779, business.industry, Research, lcsh:Diseases of the respiratory system, Recovery of Function, Triazoles, medicine.disease, Confidence interval, 030104 developmental biology, 030228 respiratory system, Pharmacodynamics, Indacaterol, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9f1a1b8340ecb4882c35fefacbfaa7eTest
https://pubmed.ncbi.nlm.nih.gov/32907566Test

8

Functional respiratory imaging assessment of glycopyrrolate and formoterol fumarate metered dose inhalers formulated using co-suspension delivery technology in patients with COPD

المؤلفون: Ilse Verlinden, Martin Jenkins, Ubaldo J. Martin, Dianne Griffis, Glenn Leemans, Jan De Backer, Earl St Rose, Jane Fitzpatrick, Stefan Ivanov, Wilfried De Backer, Colin Reisner, Cedric Van Holsbeke, Benjamin Mignot

المصدر: Therapeutic advances in respiratory disease
Therapeutic Advances in Respiratory Disease, Vol 14 (2020)
Therapeutic Advances in Respiratory Disease

مصطلحات موضوعية: Male, Time Factors, Vital Capacity, Severity of Illness Index, Pulmonary Disease, Chronic Obstructive, 0302 clinical medicine, Forced Expiratory Volume, Formoterol Fumarate, Pharmacology (medical), 030212 general & internal medicine, Respiratory system, Suspension (vehicle), Lung, Original Research, COPD, Cross-Over Studies, integumentary system, Middle Aged, Bronchodilator Agents, Treatment Outcome, Anesthesia, Female, Imaging technique, Pulmonary and Respiratory Medicine, Drug Compounding, Muscarinic Antagonists, glycopyrronium, 03 medical and health sciences, Double-Blind Method, Administration, Inhalation, medicine, long-acting muscarinic antagonist, Humans, In patient, Metered Dose Inhalers, long-acting β2-agonist, Adrenergic beta-2 Receptor Agonists, Glycopyrrolate, Aged, Plethysmography, Whole Body, lcsh:RC705-779, Respiratory imaging, business.industry, Airway Resistance, lcsh:Diseases of the respiratory system, medicine.disease, 030228 respiratory system, Spirometry, functional respiratory imaging, Human medicine, Tomography, X-Ray Computed, business, formoterol fumarate dihydrate